Navigation Links
Trial seeks 'genetic fingerprint' for predicting drug effectiveness
Date:10/3/2007

etic factors that must be addressed individually.

The UC-led national team is looking for about 70 patients across the United States with up to stage-3 gastric cancer to participate in the trial.

Prior to surgery, all study participants will have a biopsy to set baseline standards for genetic testing to determine which patients have a complete response to the multi-treatment therapy. Participants will receive daily doses of the platinum-containing drug oxaliplatin (ox-AL-ih-plah-tin, marketed as Eloxatin) for six to eight weeks.

Approved by the Food and Drug Administration, oxaliplatin is currently used to treat advanced colorectal cancer. Studies have shown the drug has fewer toxicity complications compared with other therapies.

After six weeks of chemotherapy, the patient will get five consecutive days of three-dimensional, external-beam radiation therapy. Patients will be reevaluated two to three weeks after radiation to determine if they are eligible for surgery. Those who are suitable will have another tissue biopsy after surgery.

Researchers will compare pre- and post-surgery tissue samples to obtain the genetic data necessary to establish associations between molecular markers and drug resistance, with the goal of reducing toxicity associated with chemotherapeutic agents and improving patient survival.


'/>"/>

Contact: Amanda Harper
amanda.harper@uc.edu
513-558-4657
University of Cincinnati
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. FDA Approves Human Hookworm Vaccine for Phase I Safety Trials
2. NIAID Initiates Trial of Experimental Avian Flu Vaccine
3. International trial of two microbicides begins
4. Bird Brains Show How Trial and Error May Contribute to Learning
5. Use of PET can reduce, may eliminate more strenuous drug development trials with animals
6. HIV vaccine trial breaks ground for future research
7. Roche clinical trial registry and results database launched
8. NIAID begins clinical trial of West Nile virus vaccine
9. EuroVacc 02 HIV Vaccine Trial Begins
10. Moffitt-USF head toward first human trials of anti-cancer drug that targets protein AKT
11. Compound might defeat African sleeping sickness, clinical trial beginning this month
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2008)...g the ancestors of such marine creatures as clams,...se beginning 144 million years ago with no clear t...m of researchers. This contradicts previous work s...ars ago and may shed light on future diversity. ,...ies for what is happening today from global warmin...
(Date:7/3/2008)...- A farm irrigation canal would seem a healthier p...ng lot. , But University of Florida scientists h...de implications for a longstanding debate over whe...bians, UF zoologists have found that toads in subu...tive system abnormalities than toads near farms w...
(Date:7/3/2008)...ly 3, 2008 -- Sirtris, a GlaxoSmithKline company f...e drugs to treat diseases of aging such as Type 2 ...eported in today,s online edition of Cell Metabol...-life with resveratrol showed an overall health im...tion in cataracts and cardiovascular dysfunction, ...
(Date:7/3/2008)... highly valued by consumers yet their properties h... materials, placing a drain on our limited natural...National Physical Laboratory (NPL) are working tow...redict how we perceive naturalness. The results co... are interpreted by our senses as being fully equi...
Breaking Biology News(10 mins):Species have come and gone at different rates than previously believed 2Species have come and gone at different rates than previously believed 3New study points to agriculture in frog sexual abnormalities 2New study points to agriculture in frog sexual abnormalities 3Long-term study of middle-aged mice shows 2Long-term study of middle-aged mice shows 3Scientists set out to measure how we perceive naturalness 2Scientists set out to measure how we perceive naturalness 3VR Mergers and Acquisitions Completes Transaction of Laurinburgs Community Drug 7932 1Emageon Names Chris E Perkins as Chief Operating Officer 7930 1Emageon Names Chris E Perkins as Chief Operating Officer 7930 2BSML Announces Changes in Management 7928 1BSML Announces Changes in Management 7928 2BSML Announces Changes in Management 7928 3BSML Announces Changes in Management 7928 4New study shows worlds protected areas threatened by climate change 7926 1New study shows worlds protected areas threatened by climate change 7926 2
...aquatic amphibians developed the ability to feed o...rial life, researchers from Harvard University rep...cademy of Sciences. , Their work is based on analy...rose 375 million years ago, and their fish ancesto...kull bones -- termed "sutures" -- in the tops of t...
...arch shows that a recently discovered enzyme that ...s can also help to protect the mRNA during times o...vive chemotherapy and radiation therapy. , The st...MR1. That enzyme attaches to certain mRNA molecule...in in place. , These mRNAs carry the informatio...
...heart failure resulting from dilated cardiomyopath...portions.1 Molecular mechanisms are being studied ..., e.g.: the familial forms. Intracellular [Ca2+]i ...on and integrity, and dysregulation of [Ca2+]i is ... trigger for cardiac [Ca2+]i transients is calcium...
...ere is no cure for lingering viral infections such...iversity suggests it may be possible to deactivate...etic switch. , Princeton scientists Leor Weinberg...e the processes by which human immunodeficiency vi...t phases in their hosts. The researchers have disc...
Other Biology News:Ancient amphibians evolved a bite before migrating to dry land 2Destructive enzyme shows a benevolent side 2Protein overexpression at heart of heart failure 2Scientists find potential 'off-switch' for HIV virus 2Scientists find potential 'off-switch' for HIV virus 3Scientists find potential 'off-switch' for HIV virus 4
(Date:7/3/2008)...la., July 3 /- Bioheart, In...is focused on the development,of autologous (patie...atment of chronic and acute heart damage, today an...rd J. Leonhardt, Bioheart,s co-founder, Chairman,o... as Chief Executive,Officer effective as of July 1...
(Date:7/3/2008)...uly 3 /- Advanced Life Scie...eutical company engaged in the,discovery, developm...erapeutic areas of infection, cancer and respirato...the Russell Microcap(R) Index after the,Russell In... of U.S. and,global equity indexes on June 27, 200...
(Date:7/3/2008)...lif., July 3 /- Antigen Discovery Inc...eader in high throughput,antigen/biomarker discove...nnounced today that the Company was awarded a Phas...nd Infectious Diseases (NIAID) and the,National Ce... grant will,fund efforts to further develop ADI,s ...
(Date:7/2/2008)... Mass., July 2 /- Biopure C...t has signed an agreement with,purchasers for a pr...or up,to $2.3 million in tranches, assuming no exe...the net proceeds for working capital and general,c...une 30, 2008, and,subsequent closings are subject ...
Breaking Biology Technology:Bioheart, Inc., Board Appoints Howard J. Leonhardt Chief Executive Officer 2Bioheart, Inc., Board Appoints Howard J. Leonhardt Chief Executive Officer 3Advanced Life Sciences Added to Russell Microcap Index 2Advanced Life Sciences Added to Russell Microcap Index 3Antigen Discovery Inc. Awarded a SBIR Phase II Grant to Commercialize Novel Antigens for Serodiagnostic Products and Vaccine Development 2Biopure Announces Private Equity Financing 2Biopure Announces Private Equity Financing 3
...antz Group, a direct marketing firm, has brought W...rom Milwaukee-based Brevient Technologies, Inc . ...s. , ,Brevient installed an appliance server at T...ation coincides with Brevient,s release of Connect...b conferences directly to their desktops in a vide...
...a raked devastation along the Gulf Coast, so many ... suffering of the people and speed the recovery of... see how our checks and care packages are really m...-mail from a dear friend, a social worker in Massa...ould work directly with victims of the storm. Alm...
... Here extreme manufacturing meets extreme consumpt...leftover inventories and surplus raw materials. Th...of these two elephants will result in true love. T... jealousy are the spoilers of this romantic tango ... a land many have only heard of or seen in their d...
...e to be encouraged by the numerous positive signs ...st. Here are just a few: , ,& bull; The coming of ..., ,& bull; The continued acquisition of Midwest b...ile they recognize the value of Midwest products a...e losing publicly traded companies. , ,Bone Care I...
Other Biology Technology:Frantz Group brings Web conferencing in-house 2The DEMO / Katrina Challenge 2The DEMO / Katrina Challenge 3The world's largest factory 2The world's largest factory 3The world's largest factory 4Midwest biotech on a roll 2Midwest biotech on a roll 3Midwest biotech on a roll 4
Immunogen: C terminus [VQLKRSKNDSKPYC] of cardiac elav-type RNA-binding protein (ETR-3) Storage: -20 C, Avoid Freeze/Thaw Cycles
Standard 2" and 3" Fiberboard Boxes can be sold separately or with 16, 25, 36, 49, 64, 81 or 100 cell dividers. Fiberboard boxes can also be ordered with corresponding freezer racks
EvoQuest Custom Peptide Services from Invitrogen
Luminometers
Biology Products: